[HTML][HTML] Old and new oral anticoagulants: food, herbal medicines and drug interactions

A Di Minno, B Frigerio, G Spadarella, A Ravani… - Blood reviews, 2017 - Elsevier
The most commonly prescribed oral anticoagulants worldwide are the vitamin K antagonists
(VKAs) such as warfarin. Factors affecting the pharmacokinetics of VKAs are important …

The role of amiodarone in contemporary management of complex cardiac arrhythmias

N Mujović, D Dobrev, M Marinković, V Russo… - Pharmacological …, 2020 - Elsevier
Amiodarone is an iodinated benzofuran derivative, a highly lipophilic drug with
unpredictable pharmacokinetics. Although originally classified as a class III agent due to its …

New‐onset postoperative atrial fibrillation after heart surgery

T Gudbjartsson, S Helgadottir… - Acta …, 2020 - Wiley Online Library
Background New‐onset postoperative atrial fibrillation (poAF) complicates approximately 20‐
60% of all cardiac surgical procedures and is associated with an increased periprocedural …

Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes

N Abi‐Gerges, K Philp, C Pollard… - Fundamental & …, 2004 - Wiley Online Library
A number of non‐cardiovascular drugs have been withdrawn from clinical use due to
unacceptable adverse cardiac side‐effects involving drug‐induced Torsades de Pointes …

Drug–drug interactions involving antidepressants: focus on desvenlafaxine

Y Low, S Setia, G Lima - Neuropsychiatric disease and treatment, 2018 - Taylor & Francis
Psychiatric and physical conditions often coexist, and there is robust evidence that
associates the frequency of depression with single and multiple physical conditions. More …

[HTML][HTML] Lopinavir-ritonavir in SARS-CoV-2 infection and drug-drug interactions with cardioactive medications

S Agarwal, SK Agarwal - Cardiovascular drugs and therapy, 2021 - Springer
Lopinavir-ritonavir combination is being used for the treatment of SARS-CoV-2 infection. A
low dose of ritonavir is added to other protease inhibitors to take advantage of potent …

Clinical relevance and management of drug‐related QT interval prolongation

MA Crouch, L Limon… - … : The Journal of Human …, 2003 - Wiley Online Library
Much attention recently has focused on drugs that prolong the QT interval, potentially
leading to fatal cardiac dysrhythmias (eg, torsade de pointes). We provide a detailed review …

Natural products as the calcium channel blockers for the treatment of arrhythmia: Advance and prospect

L Xiao, XJ Chen, JK Feng, WN Li, S Yuan, Y Hu - Fitoterapia, 2023 - Elsevier
Arrhythmia is one of the commonly heart diseases with observed abnormal heart-beat
rhythm that caused by the obstacles of cardiac activity and conduction. The arrhythmic …

Oral adverse drug reactions to cardiovascular drugs

LA Torpet, C Kragelund, J Reibel… - Critical reviews in oral …, 2004 - journals.sagepub.com
A great many cardiovascular drugs (CVDs) have the potential to induce adverse reactions in
the mouth. The prevalence of such reactions is not known, however, since many are …

A review on pharmacokinetic and pharmacodynamic drug interactions of adrenergic β-blockers with clinically relevant drugs-an overview

NMP Maideen, B Rajkapoor… - Current drug …, 2021 - ingentaconnect.com
Adrenergic β-blockers are used to treat many conditions, including hypertension, cardiac
arrhythmias, heart failure, angina pectoris, migraine, and tremors. The majority of the β …